Friday 6 November 2026
Export PEN’s income statement to Excel — free account
Penumbra, Inc.
PEN Healthcare Medical Devices
Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.
- Revenue
- +15.6%
- EPS
- −8.29%
- Free cash flow
- −37.2%
- Total debt
- −10.3%
Quarter to September 2026, against a year earlier
319.20
1.91
−0.59%
Follow PEN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
13.78% | 12.73% | 11.37% | 10.67% | |
Piotroski F-Score |
8 | 7 | 6 | 6 | |
| 10.58% | 9.80% | 8.80% | 8.33% | ||
ROIC |
13.09% | 13.32% | 13.13% | 12.73% | |
Return on Tangible Assets |
15.44% | 14.28% | 12.77% | 12.09% | |
Average Days of Receivables |
49.41 | 46.00 | 46.18 | 45.67 | |
Free Cash Flow per Share |
4.49 | 5.42 | 5.49 | 5.08 | |
Free Cash Flow |
174.93 | 212.73 | 215.91 | 200.29 | |
Capital Expenditures |
(63.73) | (63.93) | (61.90) | (60.75) | |
| Other line items | |||||
Cash ROIC |
8.78% | 10.08% | 9.77% | 8.80% | |
Accounts Receivable Turnover |
7.85 | 8.28 | 8.22 | 8.24 | |
Accounts Payable Turnover |
13.96 | 12.68 | 13.29 | 13.92 | |
Inventory Turnover |
1.10 | 1.11 | 1.11 | 1.12 | |
Average Days of Payables |
27.49 | 33.60 | 33.73 | 30.66 | |
Days of Inventory on Hand |
341.51 | 337.47 | 333.83 | 335.47 | |
Tax Rate |
(0.13) | (0.16) | (0.21) | (0.24) | |
Research and Development Expense of Revenue |
6.40% | 6.19% | 6.13% | 6.08% | |
Selling, General and Administrative Expense of Revenue |
47.26% | 48.32% | 49.26% | 49.77% | |
Share Based Compensation of Revenue |
4.22% | 4.13% | 3.95% | 3.74% | |
Operating CF/Net income |
1.34 | 1.62 | 1.73 | 1.66 | |
Depreciation/Fixed assets |
0.15 | 0.13 | 0.12 | 0.13 | |
Capex/Depreciation |
(3.65) | (3.75) | (3.61) | (3.02) | |
Revenue per Share |
36.07 | 37.03 | 38.24 | 39.60 | |
Operating CF per Share |
6.13 | 7.04 | 7.06 | 6.63 | |
Capex per Share |
(1.64) | (1.63) | (1.57) | (1.54) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 2 Nov 2026